🇺🇸 FDA
Pipeline program

gemcitabine and cisplatin (Induction chemotherapy)

2022-FXY-298

Phase 3 small_molecule active

Quick answer

gemcitabine and cisplatin (Induction chemotherapy) for Nasopharyngeal Carcinoma is a Phase 3 program (small_molecule) at Sun Yat-sen University with 1 ClinicalTrials.gov record(s).

Program details

Company
Sun Yat-sen University
Indication
Nasopharyngeal Carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials